13th Annual Scientific Meeting
16th - 18th May 2022
Hilton Brighton Metropole
Endorsed by IFSO
The BOMSS Annual Scientific Meeting 2022 and the BOMSS Training day has been awarded a total of 17 hours CPD by
The Association of Surgeons of Great Britain and Ireland
BOMSS welcomed delegates and industry to the 13th BOMSS Annual Scientific Meeting which took place at Hilton Brighton Metropole, from the 17th – 18th May 2022.
The meeting kicked off with BOMSS holding a Training Day for Trainee Surgeons and Integrated Healthcare Professionals on Monday 16th May 2022. The morning of the training day covered optimising weight management and dissatisfaction after Bariatric Surgery. In the afternoon, the Trainee Surgeons were able experience a hands-on laparoscopic skills training session, whilst the IHP's were exploring the experience of living with obesity.
The Annual Scientific Meeting programme took place on Tuesday 17th May and Wednesday 18th May 2022 with over 420 attendees arriving in Brighton. The programme covered all the important topics for the entire multidisciplinary team, with speakers from across the UK, Europe, USA and India.
BOMSS would like to thank all the delegates, speakers and industry for their contribution to the meeting.
All abstracts will be published in the Obesity Surgery Journal.
Royal College of Surgeons England Hunterian Lecture
How the gut talks to the brain and other organs - Dimitri Pournaras
Best Poster 2022 - Georgios Dimitriadis
Abstract Title: One anastomosis gastric bypass (OAGB) produces considerable weight loss and resolution of medical complications with an acceptable rate of nutritional deficiencies.
BOMSS Surgical Research Presentation Prize - Martin Whyte
Abstract Title: Female Sexual quality of life after bariatric surgery
Novo Nordisk has provided sponsorship to the British Obesity & Metabolic Surgery Society – Charitable Incorporate Organisation (BOMSS-CIO) to contribute towards the running costs of the BOMSS-CIO’s Annual Scientific Meeting (ASM) 2022. Novo Nordisk has had no influence over the creation, development or content of the meeting and full control remains the responsibility of BOMSS-CIO (with the exception of the Novo Nordisk symposium session indicated on the meeting programme).